Product Description
Benserazide is an inhibitor of aromatic L-amino acid decarboxylase (AADC), an enzyme that has dopamine decarboxylase activity. It blocks the conversion of L-DOPA to dopamine by AADC in the peripheral circulatory system. It causes an increase in the amount of L-DOPA reaching the central nervous system and so reduces the required dose. It is often combined with L-DOPA in patients with Parkinson’s disease.
Benserazide is an inhibitor of aromatic L-amino acid decarboxylase (AADC), an enzyme that has dopamine decarboxylase activity. It blocks the conversion of L-DOPA to dopamine by AADC in the peripheral circulatory system. It causes an increase in the amount of L-DOPA reaching the central nervous system and so reduces the required dose. It is often combined with L-DOPA in patients with Parkinson’s disease.
Biovision | B2963 | Benserazide hydrochloride DataSheet
Alternate Name/Synonyms: DL-Serine 2-(2,3,4-Trihydroxybenzyl)hydrazide Hydrochloride; 2-amino-3-hydroxy-N'-(2,3,4-trihydroxybenzyl)propanehydrazide hydrochloride; 2-amino-3-hydroxy-N'-[(2,3,4-trihydroxyphenyl)methyl]propanehydrazide, hydrochloride
Appearance: A crystalline solid
Formulation:
CAS Number: 14919-77-8
Structure Available?: True
Peptide sequence:
Salt Form: true
Molecular Formula: C₁₀H₁₆ClN₃O₅
Molecular Weight: 293.7
Cell-Permeable?: True
Purity: ≥95%
Solubilities: ~16 mg/ml in in DMSO, ~20 mg/ml in DMF in 0
Handling: Do not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
Country of Origin: USA
Tag Line: An inhibitor of aromatic L-amino acid decarboxylase (DOPA decarboxylase)
MDL Number: MFCD00078571
PubChem CID: 26964
SMILES: C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O.Cl
InChi: InChI=1S/C10H15N3O5.ClH/c11-6(4-14)10(18)13-12-3-5-1-2-7(15)9(17)8(5)16;/h1-2,6,12,14-17H,3-4,11H2,(H,13,18);1H
InChi Key: ULFCBIUXQQYDEI-UHFFFAOYSA-N